Evidence map›Paper›PMID 26761271›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2016

Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.

Laurence Slama, Lisa P Jacobson, Xiuhong Li, Frank J Palella, Joseph B Margolick, Lawrence A Kingsley, Dorothy J Wiley, Gilles Pialoux, Adrian S Dobs, Todd T Brown and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laurence Slama*Division of Infectious Diseases, Tenon Hospital, Pierre and Marie Curie University, Paris, France;†Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL;Departments of ‡Epidemiology;§Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;‖Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA;¶Division of Translational Science, School of Nursing, UCLA, Los Angeles, CA; and#Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD.
Lisa P Jacobson
Xiuhong Li
Frank J Palella
Joseph B Margolick
Lawrence A Kingsley
Dorothy J Wiley
Gilles Pialoux
Adrian S Dobs
Todd T Brown
Multicenter AIDS Cohort Study

Funding

Multicenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FLEXNER, CHARLES W. · 1985 to 2007
$37.3M
METHODOLOGICAL EXPERTISE IN INTREPRETING MACS DATAU01AI035043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBSON, LISA P · 1993 to 2011
$26.9M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) INTENSIVE PHARMACOKINETICS STUDYM01RR000048 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAMSEY-GOLDMAN, ROSALIND · 1985 to 2007
$21.1M
Center for the Analysis & Management of the Multicenter AIDS Cohort StudyUM1AI035043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI D'SOUZA, GYPSYAMBER, JACOBSON, LISA P · 2012 to 2018
$20.7M
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDYM01RR002719 · NCRR · JOHNS HOPKINS UNIVERSITY · PI EARLEY, CHRISTOPHER J · 1986 to 2007
$20.2M
Nutrition and Metabolism CoreP30DA013868 · NIDA · TUFTS UNIVERSITY BOSTON · PI TANG, ALICE M · 2002 to 2012
$10.0M
Prayer in black women with breast cancerP50AT000437 · NCCIH · JOHNS HOPKINS UNIVERSITY · PI DOBS, ADRIAN S. · 2000 to 2004
$7.9M
A randomized trial of HAART in acute/early HIV InfectionR01AI056990 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARGOLICK, JOSEPH B. · 2004 to 2008
$3.3M
Improving screening tools to better predict high-grade anal dysplasia for MSMR01CA169508 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WILEY, DOROTHY J. · 2013 to 2017
$3.1M
NCATS NIH HHS UL1 TR001079NCCIH NIH HHS K23 AT002862NCCIH NIH HHS L30 AT001867NCCIH NIH HHS P50 AT000437NCI NIH HHS R01 CA169508NCI NIH HHS R21 CA124324NCRR NIH HHS M01 RR000048NCRR NIH HHS M01 RR000052NCRR NIH HHS M01 RR000865NCRR NIH HHS M01 RR002719NHLBI NIH HHS R34 HL117344NIAID NIH HHS K24 AI120834NIAID NIH HHS R01 AI054199NIAID NIH HHS R01 AI056990NIAID NIH HHS U01 AI035042NIAID NIH HHS U01 AI035043NIAID NIH HHS UM1 AI035043NIDA NIH HHS P30 DA013868NIDA NIH HHS R01 DA012814NIDA NIH HHS R01 DA014098NIH HHS S10 OD016315
6 · The paper itself

Abstract

backgroundAging in males is associated with lower testosterone levels and a decrease in diurnal variation of testosterone secretion. Cross-sectional studies have shown lower than expected testosterone levels among HIV-infected men, but whether age-related changes in serum testosterone differ by HIV serostatus are not known.

methodsHIV-infected men from the Multicenter AIDS Cohort Study (MACS), age ≥ 45 years at highly active antiretroviral therapy initiation, who had ≥ 2 samples from the subsequent 10 years, were matched to HIV-uninfected men by age, race, MACS site, and calendar time of samples. Linear mixed-effects regression models were used to determine whether free testosterone (FT) and its rate of change differed by HIV serostatus.

resultsOne hundred eighty-two HIV-infected and 267 HIV-uninfected men were included, median age: 48.8 years (interquartile range: 45.8-53.4), median numbers of FT measurements per participant 4 (interquartile range: 3-5), 65% were drawn in the adjusted morning (AM). Mean-adjusted FT levels were lower among HIV-infected than HIV-uninfected men in AM samples {-6.1 ng/dL [95% confidence interval (CI): -9.8 to -2.4], P = 0.001}, but not in afternoon samples [-1.7 ng/dL (-6.0 to 2.6), P = 0.441]. The rate of FT decline with age did not differ by HIV serostatus: 9.2 ng/dL (95% CI: -13.4 to -5.0) per 10 years for HIV-infected vs. 7.9 ng/dL (95% CI: -10.2 to -5.5) for HIV-uninfected men, P = 0.578.

conclusionsFT decreased similarly with increasing age regardless of HIV serostatus. The lower AM, but not adjusted afternoon, FT levels among HIV-infected men compared with HIV-uninfected men suggest a loss of diurnal variation in FT levels among HIV-infected men.

Indexed as

AgedAgingAntiretroviral Therapy, Highly ActiveCross-Sectional StudiesEunuchismHIV InfectionsHumansMaleMiddle AgedProspective StudiesRegression AnalysisTestosteroneTime FactorsTestosterone

Identifiers

PMID26761271
PMCPMC4712718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.